Government-Owned Inventions; Availability for Licensing, 79508 [2016-27222]
Download as PDF
<![CDATA[
79508
Federal Register / Vol. 81, No. 219 / Monday, November 14, 2016 / Notices
for Advancing Translational Sciences, 1
Democracy Plaza, Room 1072, Bethesda, MD
20892, 301–435–0809, anna.ramseyewing@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: November 7, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–27223 Filed 11–10–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The inventions listed below
are owned by an agency of the U.S.
Government and are available for
licensing in the U.S. in accordance with
35 U.S.C. 209 and 37 CFR part 404 to
achieve expeditious commercialization
of federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Licensing information and copies of the
U.S. patent applications listed below
may be obtained by writing to the
indicated licensing contact at the
National Heart, Lung and Blood
Institute, Office of Technology Transfer
and Development, National Institutes of
Health, 31 Center Drive, Room 4A29,
MSC2479, Bethesda, MD 20892–2479;
telephone: 301–402–5579. A signed
Confidential Disclosure Agreement may
be required to receive copies of the
patent applications.
SUPPLEMENTARY INFORMATION:
Technology descriptions follow.
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
Immortalized Organ of Corti Cell Line
OC-k3 Description of Technology
Available for nonexclusive licensing
as a research material is a conditionally
immortalized Organ of Corti cell line
called OC-k3. Sensory cells from the
auditory organ, the Organ of Corti, are
terminally differentiated and cannot be
cultured. Moreover, few of them can be
isolated per cochlea and survive only
VerDate Sep<11>2014
17:26 Nov 10, 2016
Jkt 241001
few hours after isolation making
impossible to use on them many
biochemical and molecular biology
techniques. OC-k3, expresses many
markers of sensory cells and it has
already been used as an in vitro model
for a variety of studies.
Potential Commercial Applications
• Research
• Hearing research
• Susceptibility to ototoxic drugs
Development Stage
• Materials
Inventors: Gilda Mabel Canseco de
Kalinec and Federico Kalinec (both of
NIDCD).
Publications
1. Bertolaso L, et al. (2001)
‘‘Apoptosis in the OC-k3 immortalized
cell line treated with different agents.’’
Audiology 40:327–335. PMID:
1178104637–5745.
2. Previati M, et al. (2007) ‘‘Cisplatin
cytotoxicity in Organ of Corti-derived
immortalized cells.’’ J Celt
Biochem.101(5):1185–97, PMID:
7243113.
Intellectual Property: HHS Reference
No. E–012–2017/0—Research Material.
Licensing Contact: Michael
Shmilovich, Esq, CLP; 301–435–5019;
shmilovm@mail.nih.gov.
Dated: November 7, 2016.
Michael Shmilovich,
National Heart, Lung and Blood Institute,
Office of Technology Transfer and
Development, National Institutes of Health.
[FR Doc. 2016–27222 Filed 11–10–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
[Docket No. DHS–2016–0083]
Privacy Act of 1974; Computer
Matching Program
U.S. Citizenship and
Immigration Services, Department of
Homeland Security.
ACTION: Notice of Recertification.
AGENCY:
This document provides
notice of the existence of a computer
matching program between the
Department of Homeland Security, U.S.
Citizenship and Immigration Services
and the New Jersey Department of Labor
and Workforce Development, titled
‘‘Verification Division DHS–USCIS/NJ–
LWD.’’
SUPPLEMENTARY INFORMATION: The
Department of Homeland Security, U.S.
SUMMARY:
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
Citizenship and Immigration Services
provides this notice in accordance with
the Privacy Act of 1974 (5 U.S.C. 552a),
as amended by the Computer Matching
and Privacy Protection Act of 1988
(Public Law 100–503) and the Computer
Matching and Privacy Protection
Amendments of 1990 (Public Law 101–
508) (Privacy Act); Office of
Management and Budget (OMB) Final
Guidance Interpreting the Provisions of
Public Law 100–503, the Computer
Matching and Privacy Protection Act of
1988, 54 FR 25818 (June 19, 1989); and
appendix I to OMB’s Revision of
Circular No. A–130 (November 28,
2000), ‘‘Transmittal Memorandum No.
4, Management of Federal Information
Resources.’’
Participating Agencies: The
Department of Homeland Security, U.S.
Citizenship and Immigration Services
(DHS–USCIS) is the source agency and
the New Jersey Department of Labor and
Workforce Development (NJ–LWD) is
the recipient agency.
Purpose of the Match: The purpose of
this Agreement is to establish the terms
and conditions governing NJLWD’s
access to, and use of, the DHS–USCIS
Systematic Alien Verification for
Entitlements (SAVE) Program, which
provides immigration status information
from Federal immigration records to
authorized users, and to comply with
the Computer Matching and Privacy
Protection Act of 1988.
New Jersey Department of Labor and
Workforce Development will use the
SAVE Program to verify the immigration
status of non U.S. citizens who apply for
benefits (Benefit Applicants) under the
Unemployment Compensation (UC)
benefits that it administers. Under
Federal law, immigrant workers must be
in particular immigration categories to
qualify for UC benefits. NJLWD will use
the information obtained through the
SAVE Program to determine whether
Benefit Applicants possess the requisite
immigration status to be eligible for the
UC benefits administered by NJLWD.
Authority for Conducting the
Matching Program: Section 121 of the
Immigration Reform and Control Act
(IRCA) of 1986, Public Law 99–603, as
amended by the Personal Responsibility
and Work Opportunity Reconciliation
Act of 1996 (PRWORA), Public Law
104–193, 110 Stat. 2168 (1996), requires
DHS to establish a system for the
verification of immigration status of
alien applicants for, or recipients of,
certain types of benefits as specified
within IRCA, and to make this system
available to state agencies that
administer such benefits. Section 121(c)
of IRCA amends sec. 1137 of the Social
Security Act and certain other sections
E:\FR\FM\14NON1.SGM
14NON1
]]>Agencies
[Federal Register Volume 81, Number 219 (Monday, November 14, 2016)]
[Notices]
[Page 79508]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-27222]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions; Availability for Licensing
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The inventions listed below are owned by an agency of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 209 and 37 CFR part 404 to achieve expeditious
commercialization of federally-funded research and development. Foreign
patent applications are filed on selected inventions to extend market
coverage for companies and may also be available for licensing.
FOR FURTHER INFORMATION CONTACT: Licensing information and copies of
the U.S. patent applications listed below may be obtained by writing to
the indicated licensing contact at the National Heart, Lung and Blood
Institute, Office of Technology Transfer and Development, National
Institutes of Health, 31 Center Drive, Room 4A29, MSC2479, Bethesda, MD
20892-2479; telephone: 301-402-5579. A signed Confidential Disclosure
Agreement may be required to receive copies of the patent applications.
SUPPLEMENTARY INFORMATION: Technology descriptions follow.
Immortalized Organ of Corti Cell Line OC-k3 Description of Technology
Available for nonexclusive licensing as a research material is a
conditionally immortalized Organ of Corti cell line called OC-k3.
Sensory cells from the auditory organ, the Organ of Corti, are
terminally differentiated and cannot be cultured. Moreover, few of them
can be isolated per cochlea and survive only few hours after isolation
making impossible to use on them many biochemical and molecular biology
techniques. OC-k3, expresses many markers of sensory cells and it has
already been used as an in vitro model for a variety of studies.
Potential Commercial Applications
Research
Hearing research
Susceptibility to ototoxic drugs
Development Stage
Materials
Inventors: Gilda Mabel Canseco de Kalinec and Federico Kalinec
(both of NIDCD).
Publications
1. Bertolaso L, et al. (2001) ``Apoptosis in the OC-k3 immortalized
cell line treated with different agents.'' Audiology 40:327-335. PMID:
1178104637-5745.
2. Previati M, et al. (2007) ``Cisplatin cytotoxicity in Organ of
Corti-derived immortalized cells.'' J Celt Biochem.101(5):1185-97,
PMID: 7243113.
Intellectual Property: HHS Reference No. E-012-2017/0--Research
Material.
Licensing Contact: Michael Shmilovich, Esq, CLP; 301-435-5019;
shmilovm@mail.nih.gov.
Dated: November 7, 2016.
Michael Shmilovich,
National Heart, Lung and Blood Institute, Office of Technology Transfer
and Development, National Institutes of Health.
[FR Doc. 2016-27222 Filed 11-10-16; 8:45 am]
BILLING CODE 4140-01-P
